IT201700082678A1 - “Associazione di Salvia Miltiorrhiza Bunge e vitamine K1 e/o K2 per il trattamento di varie patologie legate alle alterazioni dell’osteogenesi” - Google Patents

“Associazione di Salvia Miltiorrhiza Bunge e vitamine K1 e/o K2 per il trattamento di varie patologie legate alle alterazioni dell’osteogenesi”

Info

Publication number
IT201700082678A1
IT201700082678A1 IT102017000082678A IT201700082678A IT201700082678A1 IT 201700082678 A1 IT201700082678 A1 IT 201700082678A1 IT 102017000082678 A IT102017000082678 A IT 102017000082678A IT 201700082678 A IT201700082678 A IT 201700082678A IT 201700082678 A1 IT201700082678 A1 IT 201700082678A1
Authority
IT
Italy
Prior art keywords
osteogenesis
vitamins
alterations
association
treatment
Prior art date
Application number
IT102017000082678A
Other languages
English (en)
Inventor
Gianfranco Caramelli
Alberto Caramelli
Eleonora Caramelli
Leonardo Caramelli
Andrea Caramelli
Original Assignee
Gianfranco Caramelli
Alberto Caramelli
Eleonora Caramelli
Leonardo Caramelli
Andrea Caramelli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gianfranco Caramelli, Alberto Caramelli, Eleonora Caramelli, Leonardo Caramelli, Andrea Caramelli filed Critical Gianfranco Caramelli
Priority to IT102017000082678A priority Critical patent/IT201700082678A1/it
Publication of IT201700082678A1 publication Critical patent/IT201700082678A1/it

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/53Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A61K36/537Salvia (sage)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/12Ketones
    • A61K31/122Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
IT102017000082678A 2017-07-20 2017-07-20 “Associazione di Salvia Miltiorrhiza Bunge e vitamine K1 e/o K2 per il trattamento di varie patologie legate alle alterazioni dell’osteogenesi” IT201700082678A1 (it)

Priority Applications (1)

Application Number Priority Date Filing Date Title
IT102017000082678A IT201700082678A1 (it) 2017-07-20 2017-07-20 “Associazione di Salvia Miltiorrhiza Bunge e vitamine K1 e/o K2 per il trattamento di varie patologie legate alle alterazioni dell’osteogenesi”

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT102017000082678A IT201700082678A1 (it) 2017-07-20 2017-07-20 “Associazione di Salvia Miltiorrhiza Bunge e vitamine K1 e/o K2 per il trattamento di varie patologie legate alle alterazioni dell’osteogenesi”

Publications (1)

Publication Number Publication Date
IT201700082678A1 true IT201700082678A1 (it) 2017-10-20

Family

ID=60990943

Family Applications (1)

Application Number Title Priority Date Filing Date
IT102017000082678A IT201700082678A1 (it) 2017-07-20 2017-07-20 “Associazione di Salvia Miltiorrhiza Bunge e vitamine K1 e/o K2 per il trattamento di varie patologie legate alle alterazioni dell’osteogenesi”

Country Status (1)

Country Link
IT (1) IT201700082678A1 (it)

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009146490A1 (en) * 2008-06-03 2009-12-10 John Ray Biffin A method for increasing bone density and/or reducing any osteochondral defects in an animal and a composition including vitamin k
CN104839664A (zh) * 2015-04-10 2015-08-19 劲膳美生物科技股份有限公司 骨质疏松医学配方食品
CN105878374A (zh) * 2016-04-12 2016-08-24 程凤森 一种含丹参脂溶性成分和辅酶q10的组合物及其制备方法及采用该组合物的药物
PL414902A1 (pl) * 2015-11-23 2017-06-05 Sequoia Spółka Z Ograniczoną Odpowiedzialnością Kompozycja farmaceutyczna zawierająca połączenie witamin K1 i K2 oraz jej zastosowanie

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009146490A1 (en) * 2008-06-03 2009-12-10 John Ray Biffin A method for increasing bone density and/or reducing any osteochondral defects in an animal and a composition including vitamin k
CN104839664A (zh) * 2015-04-10 2015-08-19 劲膳美生物科技股份有限公司 骨质疏松医学配方食品
PL414902A1 (pl) * 2015-11-23 2017-06-05 Sequoia Spółka Z Ograniczoną Odpowiedzialnością Kompozycja farmaceutyczna zawierająca połączenie witamin K1 i K2 oraz jej zastosowanie
CN105878374A (zh) * 2016-04-12 2016-08-24 程凤森 一种含丹参脂溶性成分和辅酶q10的组合物及其制备方法及采用该组合物的药物

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
DATABASE WPI Week 201612, Derwent World Patents Index; AN 2015-62684T, XP002780147 *
DATABASE WPI Week 201675, Derwent World Patents Index; AN 2016-60378E, XP002780148 *
DATABASE WPI Week 201820, Derwent World Patents Index; AN 2018-17847R, XP002780149 *
GUO YUBO ET AL: "Salvia miltiorrhiza: An ancient Chinese herbal medicine as a source for anti-osteoporotic drugs", JOURNAL OF ETHNOPHARMACOLOGY, ELSEVIER IRELAND LTD, IE, vol. 155, no. 3, 7 August 2014 (2014-08-07), pages 1401 - 1416, XP029057377, ISSN: 0378-8741, DOI: 10.1016/J.JEP.2014.07.058 *

Similar Documents

Publication Publication Date Title
EA201800199A1 (ru) Применение akkermansia muciniphila для лечения метаболических расстройств, увеличения расхода энергии и снижения веса, композиции, лекарственное стедство
PH12018500087A1 (en) 1,1,1-trifluoro-3-hydroxypropan-2-yl carbamate derivatives and 1,1,1-trifluoro-4-hydroxybutan-2-yl carbamate derivatives as magl inhibitors
SA519410311B1 (ar) أجسام بيتا ببتيد النشوانية المضادة لـ N3pGlu واستخداماتها
PT3377637T (pt) Composições para uso em métodos para o tratamento de ferimentos, transtornos e doenças da pele
IL273550A (en) Inhibition of HSD17B13 in the treatment of liver disease in patients expressing the I148M variant of PNPLA3
MA49141A (fr) Composés pyrrolopyridine-aniline destinés au traitement d'affections de la peau
MA51056A (fr) Compositions et méthodes pour le traitement d'affections métaboliques
EP3583113A4 (en) USE OF TGF-ALPHA FOR TREATMENT OF DISEASES AND DISORDERS
IT201600121601A1 (it) Composizione orale per il trattamento del reflusso gastroesofageo e del reflusso laringo-faringeo
BR112018010155A2 (pt) segmentação do receptor formil-peptídeo 2/receptor lipoxina a4 (fpr2/alx) para tratamento de doença cardíaca
HK1257583A1 (zh) 預防和治療脂肪代謝紊亂及其相關病症的藥物及其用途
IL276786A (en) Compounds and compositions for the treatment of muscular disorders and bone disorders
IL281244A (en) Therapeutic combination for the treatment of liver diseases
IL269400A (en) Medicines and preparations for the treatment of eye disorders
MX2018015208A (es) Andrografolido para tratar formas progresivas de esclerosis multiple.
IT201700085412A1 (it) Composizione per uso nella prevenzione e nel trattamento di patologie dell'apparato cardiovascolare
IT201700082678A1 (it) “Associazione di Salvia Miltiorrhiza Bunge e vitamine K1 e/o K2 per il trattamento di varie patologie legate alle alterazioni dell’osteogenesi”
MA53636A (fr) Agent de traitement de troubles dermatologiques
MA50458A (fr) Formulations topiques destinées au traitement d'affections dermatologiques comprenant la calvitie hippocratique
IT201700111261A1 (it) Composizione per il trattamento delle neuropatie metaboliche e meccaniche
MA43001A (fr) Cannabidiol et hu-211 pour le traitement d'une lésion cérébrale traumatique
IT201700057247A1 (it) Agenti chelanti per il trattamento di disturbi nutrizionali di piante
KR20180085033A (ko) 피부 질환 치료용 약학적 제형 및 이의 제조 방법
GB2609793B (en) Benzimidazole compound for the treatment of metabolic disorders and liver diseases
GB201819758D0 (en) Medicine for the treatment of Alzheimer's disease